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Streptomyces pneumonia in an immunocompetent adult 
— a rare isolate
Abstract
Streptomyces belongs to the Actinomycetes group of bacteria which are gram-positive non acid-fast bacilli, widely recognised for 
their potential to produce antimicrobials active against bacterial, mycobacterial, parasitic and fungal infections. They commonly 
cause cutaneous infections following traumatic inoculation. Visceral infections are relatively rare and limited to immunocompro-
mised hosts. We describe a case of Streptomyces pneumonia in a healthy immunocompetent female, who when investigated 
for voluntary kidney donation, resulted in the isolation of Streptomyces species from bronchial wash cultures. Streptomyces, 
a potential pathogen in immunocompetent hosts is frequently underdiagnosed. Once isolated, both physicians and microbiologists 
should pay attention to differentiate true infection from contamination.
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Introduction
Streptomyces is an organism that is celebrated 
since time immemorial due to its great contribu-
tion to medicine in the form of many excellent 
antimicrobials. It is well known that Streptomyces 
causes superficial skin and soft tissue infections 
following traumatic inoculation, the most com-
mon of which being Mycetoma in the feet of 
farmers, a chronic suppurative infection of the 
skin and underlying soft tissue [1]. It rarely causes 
bacteremia, pneumonia, and other visceral infec-
tions in the backdrop of immunocompromised 
states. We herein report the occurrence of Strepto-
myces pneumonia in an immunocompetent adult 
and discuss its varied clinical manifestations, 
radiological features, diagnostic challenges, and 
treatment recommendations. 
Case details
A 49-year-old non-smoking female visited our 
respiratory outpatient clinic to receive a fitness 
certificate in order to become a kidney donor. She 
wished to donate one of her kidneys to her brother. 
Detailed history revealed that she had a cough 
with purulent expectoration for 5 days. There 
was no history suggestive of pulmonary tuber-
culosis, chronic respiratory tract illness, or any 
immunocompromised state. She is a homemak-
er and there is no history of environmental or 
workplace exposure to dust or moldy hay. No 
previous significant medical history was noted. 
On examination, she was comfortable at rest. 
Her heart rate was 70 beats/min, blood pressure 
110/70 mmHg, oxygen saturation 98% on room 
air, and respiratory rate 20 breaths/min. On chest 
auscultation, bilateral normal vesicular breath 
sounds were heard. Routine blood investigations 
were unremarkable. The chest radiograph was 
normal. However, high resolution computed to-
mography (HRCT) of the thorax showed bilateral 
tree-in-bud nodules in the right middle lobe and 
left lingula (Figure 1) which prompted us to inves-
tigate further for the cause of infection. Sputum 
pyogenic culture, acid-fast bacilli staining, and 
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a cartridge-based nucleic acid amplification test 
yielded negative results. She was treated with 
amoxicillin-clavulanic acid and azithromycin em-
pirically for 5 days, but the symptoms persisted. 
Hence, fiberoptic bronchoscopy was completed. 
Bronchial washings grew Streptomyces species 
along with Streptococcus pneumoniae. Modified 
Ziehl-Neelsen staining showed thin, non acid-fast 
filaments of Streptomyces species (Figure 2), and 
blood agar showed non-hemolytic, dry, and whit-
ish colonies of Streptomyces species (Figure 3). 
Bronchial wash mycobacterial culture and fungal 
culture yielded no other pathogen. She was treated 
with trimethoprim-sulfamethoxazole for Strepto-
myces infection based on antimicrobial sensitivity 
testing for 1 month. On follow-up, marked clinical 
and radiological resolution was observed.
Discussion
Streptomyces are aerobic, gram-positive, fil-
amentous bacteria that are negative for acid-fast 
stain and classified under the order Actinomy-
cetales [1]. The presence of extensive branched 
aerial hyphae with long chains of conidia gives 
them a characteristic appearance [1]. Once upon 
a time, these microorganisms were classified as 
fungi due to the presence of true aerial hyphae, 
but are now reclassified as bacteria. The natural 
habitat is soil as it supports the mycelial growth 
of the bacteria. The Streptomyces genus is widely 
known as the largest antimicrobial producing 
genus as it produces many antibacterials, antifun-
gals, antiparasitic agents, immunosuppressants, 
and other bioactive compounds. Antimicrobial 
agents produced from the Streptomyces genus 
include Chloramphenicol, Streptomycin, Fosfo-
mycin, Daptomycin, Lincomycin, Neomycin, Pu-
romycin, Tetracyclines, and Clavulanic acid just 
to name a few [2]. More than 3,100 Streptomyces 
species are known so far [1].  
Visceral infections are rare and commonly 
occur in immunocompromised states caused by 
cancer, chemotherapy, acquired immunodeficien-
cy syndrome or human immunodeficiency virus 
infection, Crohn’s disease, Cushing’s syndrome, 
and exogenous steroid use. They can also occur 
due to the presence of foreign material like central 
venous catheters or prosthetic heart valves [4–6]. 
Our case is unusual as the microorganism was 
isolated from the bronchial wash of an immuno-
competent adult. Very few cases of Streptomyces 
pneumonia in immunocompetent individuals 
have been reported in the literature to date [7].
Cases of Streptomyces pneumonia can pres-
ent with complaints of fever, productive cough, 
hemoptysis, breathlessness, and pleuritic chest 
pain [8, 9]. It can also cause septicemia. Chest 
computed tomography (CT) features are varied 
and can include nodular infiltrates, abscesses, 
consolidations, interstitial infiltrates with inter-
stitial thickening, hypersensitivity pneumonitis, 
pleural effusions, empyema, hilar adenopathy, 
and mediastinal lymphadenopathy [8, 9]. Our 
patient presented with cough with expectoration, 
a normal chest radiograph, and tree-in-bud nod-
ules in chest CT imaging.
Streptomyces species have also been isolated 
in cases of lymphadenitis, pericarditis, endocardi-
tis, monoarthritis, brain abscess, peritonitis, liver 
abscess, and dental caries. The outcome has been 
fairly good in the majority of these cases with 
resolution of infection [3]. However, Streptomy-
ces species were not described as the principal 
pathogen in many of these reports. Hence, the 
role of Streptomyces becomes confusing and con-
Figure 1. High resolution computed tomography of the thorax showing tree in bud nodules in right middle lobe and left lingula
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troversial when isolated from visceral infections 
along with other primary pathogens. This makes 
isolation of organisms from sterile sources and 
the prevention of contamination of specimens 
important to diagnose the true infection. In our 
case, Streptomyces was isolated from bronchial 
wash ruling out the possibility of contamination. 
Although Streptococcus pneumoniae was isolated 
along with Streptomyces, there was no clinical or 
radiological improvement following empirical 
antibiotics. Hence, we assume Streptomyces to 
be the primary pathogen. In addition, there was 
clinical and radiological resolution following 
treatment with a sensitive antibiotic. 
Streptomyces infection poses a diagnostic 
challenge. Streptomyces pneumonia was un-
derdiagnosed in the past due to the diagnostic 
constraints and paucity of molecular meth-
ods. Diagnosis depends on clinical features and 
laboratory isolation of the bacteria. Diagnostic 
methods include pyogenic culture of sputum, 
bronchoalveolar lavage in cases of consolidation 
and lung abscess, pyogenic culture of pleural 
fluid, pleural biopsy in cases of pleural effusions, 
fine needle aspiration cytology or biopsy in the 
presence of peripheral nodules, and blood culture 
in the presence of septicemia [8]. The isolate 
is identified based on its colonial morphology 
and negative acid-fast staining. Histopatholog-
ical examination may reveal the presence of 
granulomas associated with focal necrosis. This 
resemblance to mycobacteria makes it difficult to 
distinguish one from the other. Bacterial culture 
is used to confirm the diagnosis in such puzzling 
cases. Other features include sensitivity to lyso-
zymes, a positive catalase test, positive gelatin, 
and hydrolysis of casein, tyrosine, and xanthine 
[7]. Recent advances in biotechnology helps in the 
identification of Streptomyces by sequence anal-
ysis of the 16S rRNA gene [10]. Isolation of the 
pathogen from sterile sources, direct microscopic 
identification of infected tissue, and exclusion of 
other causes are considered important. At least 
two of the above criteria is necessary to diagnose 
true infection [9].
Since there is a dearth of well-documented 
cases and treatment recommendations for vis-
ceral infections caused by Streptomyces species, 
treatment is based on in vitro antimicrobial sus-
ceptibility testing and analogous data from the 
management of Nocardia infections. Kapadia et 
al. illustrated that Streptomyces organisms were 
consistently susceptible to amikacin, frequently 
susceptible to imipenem, clarithromycin, eryth-
romycin, minocycline, and trimethoprim-sul-
famethoxazole, and infrequently susceptible to 
ciprofloxacin and ampicillin [8]. Kofteridis et al. 
reported that the most potent drugs were mino-
cycline, imipenem, erythromycin, doxycycline, 
and an aminoglycoside, whereas a significant 
percentage were resistant to trimethoprim-sulfa-
methoxazole, ampicillin, and ciprofloxacin [7]. In 
the CDC evaluation of the antimicrobial suscep-
tibility of Streptomyces griseus, the most potent 
Figure 2. Modified Ziehl-Neelsen stain demonstrating thin non acid 
fast filaments of Streptomyces spp. (×1000)
Figure 3. Blood agar showing non hemolytic, dry, whitish colony of 
Streptomyces spp.
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drugs were found to be minocycline, imipenem, 
erythromycin, and doxycycline with more than 
80% of the strains susceptible to these drugs [1]. 
It is interesting to note that 29% of these strains 
were resistant to trimethoprim-sulfamethoxazole. 
Unlike Streptomyces, trimethoprim-sulfamethox-
azole is considered to be the antimicrobial of 
choice for Nocardia, which belongs to the same 
class. These data provide valuable guidance and 
solutions for empiric management while await-
ing a strain-specific susceptibility report. These 
also emphasize the importance of strain-specific 
susceptibility data for the optimal management 
of Streptomyces infections as antimicrobial resis-
tance varies markedly among species. 
Streptomyces usually demands a long treat-
ment duration as they are slow-growing bacteria. 
A treatment duration of 6 to 24 weeks has been 
reported in the literature [9]. However, the host 
immunity, site of isolation, and chronicity of 
infection also play a central role in deciding treat-
ment duration. Streptomyces infection generally 
carries a good prognosis. 
Conclusion
Streptomyces pneumonia, though rare, 
should be considered in the differential diagnosis 
of interstitial pneumonia in immunocompetent 
adults. It is important to differentiate between 
contamination and true infection. Streptomyces 
infection usually warrants a longer treatment 
duration. Limited clinical experience thus far 
warrants further studies in order to improve 
knowledge of the genus Streptomyces, its natural 
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